Kungshusen Medicinska has been acquired by Diploma
Kungshusen Medicinska AB has been acquired by Diploma PLC. Through the acquisition, Diploma gains access to a unique platform for the distribution of medtech products in Sweden.
Founded in 1977, Kungshusen is a leading Swedish distributor of medtech products in endoscopy and diathermy. The company has established a solid supplier network comprising leading international manufacturers of high-quality products and has built a strong reputation in the market based on its one-stop shop offering, high deliverability and vast sector experience. Headquartered in Mariefred, Kungshusen serves healthcare providers in all major regions of Sweden. Kungshusen’s revenues amount to approximately US$14 million.
Diploma is a UK-listed international group supplying specialized products and services within seals, controls and life sciences. Within the life sciences segment, the company supplies clinical diagnostics instruments and surgical medical devices to hospitals, clinics and laboratories, primarily in Canada, Europe and Australia. Diploma’s revenues amount to approximately US$740 million.
Oaklins’ Swedish team was engaged to run a structured sale process and advised the seller throughout the transaction.
CEO and Co-owner, Kungshusen Medicinska AB
Sprechen Sie mit dem Deal Team
Managing PartnerStockholm, Schweden
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.Mehr erfahren
Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes
Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.Mehr erfahren
Biosynex has acquired Para’kito
Biosynex has acquired Para’kito, operated by Hong-Kong based Evergreen Land Ltd. The transaction includes assets and IP and the exclusive right to commercialize the brand in Europe, Africa and South America.Mehr erfahren